Please login to the form below

Not currently logged in
Email:
Password:

generic drugs

This page shows the latest generic drugs news and features for those working in and with pharma, biotech and healthcare.

US states sue generic firms over ‘inflated’ prices

US states sue generic firms over ‘inflated’ prices

Prices for hundreds of generic drugs have risen – while some have skyrocketed, without explanation,” it says. ... The first – which is still pending – was submitted in 2016 and covers 18 corporate defendants, two individual defendants, and 15

Latest news

More from news
Approximately 3 fully matching, plus 266 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    The main drivers of revenue for Roche are well-established, standard-of-care blockbuster oncology drugs including Rituxan, Herceptin and Avastin. ... Roche will likely take the biggest loss in Europe, where nationalised healthcare systems are keen to

  • Deal Watch June 2016 Deal Watch June 2016

    The three deals with Mayne Pharma, Impax Laboratories and Dr Reddy's, for a combined value of over $1.5bn, cover portfolios of marketed and approved generic drugs, drugs currently pending ... 8 generic drugs - filed ANDAs pending approval and an approved

  • Cost containment and the German market Cost containment and the German market

    They represent an established instrument of cost control, especially in the generic segment, as 93% of all drugs under rebate contract are generics. ... Focusing on patented drugs, the price difference to the generic segment is significant.

  • Deal Watch February 2016 Deal Watch February 2016

    Licensor Acquired/Licensee Acquirer. Product/Technology. Deal Type. Headline ($m). Meda/Mylan. portfolio of branded, OTC and generic drugs.

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    Today  . Per the legislation, generic drugs will have to pay an additional rebate on top of the basic rebate. ... As a result, 340B prices for generic drugs may be lowered as Medicaid URAs become higher.

More from intelligence
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Elite Pharma names Actavis VP as CEO Elite Pharma names Actavis VP as CEO

    These include 12 generic drugs already approved by the US Food and Drug Administration (FDA) but are yet to be marketed. ... An additional generic product is under review. “Nasrat has broad experience in both branded and generic pharmaceuticals as well

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics